Early Prognostic Factors Associated with the Efficacy of Infliximab Treatment for Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate
Crossref DOI link: https://doi.org/10.1007/s40744-015-0022-y
Published Online: 2015-12-11
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hayashi, Satoko
Suzuki, Katsuya
Yoshimoto, Keiko
Takeshita, Masaru
Kurasawa, Takahiko
Yamaoka, Kunihiro
Takeuchi, Tsutomu